Recurrent Congenital Heart Block Due to Maternal Anti-Ro Antibodies: Successful Prevention of Poor Pregnancy Outcome with Hydroxychloroquine and Added Dexamethasone

MLA

Brindusa Cimpoca-Raptis, et al. “Recurrent Congenital Heart Block Due to Maternal Anti-Ro Antibodies: Successful Prevention of Poor Pregnancy Outcome with Hydroxychloroquine and Added Dexamethasone.” Reproductive Medicine, vol. 3, no. 1, Feb. 2022, pp. 36–41. EBSCOhost, https://doi.org/10.3390/reprodmed3010004.

APA

Brindusa Cimpoca-Raptis, Anca Marina Ciobanu, Nicolae Gica, Ana Maria Scutelnicu, Alexandra Bouariu, Mihaela Popescu, & Anca Maria Panaitescu. (2022). Recurrent Congenital Heart Block Due to Maternal Anti-Ro Antibodies: Successful Prevention of Poor Pregnancy Outcome with Hydroxychloroquine and Added Dexamethasone. Reproductive Medicine, 3(1), 36–41. https://doi.org/10.3390/reprodmed3010004

Chicago

Brindusa Cimpoca-Raptis, Anca Marina Ciobanu, Nicolae Gica, Ana Maria Scutelnicu, Alexandra Bouariu, Mihaela Popescu, and Anca Maria Panaitescu. 2022. “Recurrent Congenital Heart Block Due to Maternal Anti-Ro Antibodies: Successful Prevention of Poor Pregnancy Outcome with Hydroxychloroquine and Added Dexamethasone.” Reproductive Medicine 3 (1): 36–41. doi:10.3390/reprodmed3010004.